1 Report Overview |
|
1.1 Study Scope |
|
1.2 Market Analysis by Type |
|
| 1.2.1 Global Nuclear Medicine Isotopes Market Size Growth Rate by Type: 2020 VS 2026 | |
| 1.2.2 Stable Isotopes | |
| 1.2.3 Radioisotopes | |
1.3 Market by Application |
|
| 1.3.1 Global Nuclear Medicine Isotopes Market Share by Application: 2020 VS 2026 | |
| 1.3.2 Nuclear Therapy | |
| 1.3.3 Equipment Radioactive Source | |
| 1.3.4 Diagnosis | |
1.4 Study Objectives |
|
1.5 Years Considered |
|
2 Global Growth Trends |
|
2.1 Global Nuclear Medicine Isotopes Market Perspective (2015-2026) |
|
2.2 Global Nuclear Medicine Isotopes Growth Trends by Regions |
|
| 2.2.1 Nuclear Medicine Isotopes Market Size by Regions: 2015 VS 2020 VS 2026 | |
| 2.2.2 Nuclear Medicine Isotopes Historic Market Share by Regions (2015-2020) | |
| 2.2.3 Nuclear Medicine Isotopes Forecasted Market Size by Regions (2021-2026) | |
2.3 Industry Trends and Growth Strategy |
|
| 2.3.1 Market Trends | |
| 2.3.2 Market Drivers | |
| 2.3.3 Market Challenges | |
| 2.3.4 Market Restraints | |
3 Competition Landscape by Key Players |
|
3.1 Global Top Nuclear Medicine Isotopes Players by Market Size |
|
| 3.1.1 Global Top Nuclear Medicine Isotopes Players by Revenue (2015-2020) | |
| 3.1.2 Global Nuclear Medicine Isotopes Revenue Market Share by Players (2015-2020) | |
3.2 Global Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) |
|
3.3 Players Covered: Ranking by Nuclear Medicine Isotopes Revenue |
|
3.4 Global Nuclear Medicine Isotopes Market Concentration Ratio |
|
| 3.4.1 Global Nuclear Medicine Isotopes Market Concentration Ratio (CR5 and HHI) | |
| 3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Isotopes Revenue in 2019 | |
3.5 Key Players Nuclear Medicine Isotopes Area Served |
|
3.6 Key Players Nuclear Medicine Isotopes Product Solution and Service |
|
3.7 Date of Enter into Nuclear Medicine Isotopes Market |
|
3.8 Mergers & Acquisitions, Expansion Plans |
|
4 Nuclear Medicine Isotopes Breakdown Data by Type (2015-2026) |
|
4.1 Global Nuclear Medicine Isotopes Historic Market Size by Type (2015-2020) |
|
4.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Type (2021-2026) |
|
5 Nuclear Medicine Isotopes Breakdown Data by Application (2015-2026) |
|
5.1 Global Nuclear Medicine Isotopes Historic Market Size by Application (2015-2020) |
|
5.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Application (2021-2026) |
|
6 North America |
|
| 轉(zhuǎn)~自：http://www.5269660.cn/1/01/2020-2026-Global-Nuclear-Medicine-Isotopes-Industry-In-Depth-Research-and-Trends-Analysi.html | |
6.1 North America Nuclear Medicine Isotopes Market Size (2015-2026) |
|
6.2 North America Nuclear Medicine Isotopes Market Size by Type (2015-2020) |
|
6.3 North America Nuclear Medicine Isotopes Market Size by Application (2015-2020) |
|
6.4 North America Nuclear Medicine Isotopes Market Size by Country (2015-2020) |
|
| 6.4.1 United States | |
| 6.4.2 Canada | |
7 Europe |
|
7.1 Europe Nuclear Medicine Isotopes Market Size (2015-2026) |
|
7.2 Europe Nuclear Medicine Isotopes Market Size by Type (2015-2020) |
|
7.3 Europe Nuclear Medicine Isotopes Market Size by Application (2015-2020) |
|
7.4 Europe Nuclear Medicine Isotopes Market Size by Country (2015-2020) |
|
| 7.4.1 Germany | |
| 7.4.2 France | |
| 7.4.3 U.K. | |
| 7.4.4 Italy | |
| 7.4.5 Russia | |
| 7.4.6 Nordic | |
| 7.4.7 Rest of Europe | |
8 China |
|
8.1 China Nuclear Medicine Isotopes Market Size (2015-2026) |
|
8.2 China Nuclear Medicine Isotopes Market Size by Type (2015-2020) |
|
8.3 China Nuclear Medicine Isotopes Market Size by Application (2015-2020) |
|
8.4 China Nuclear Medicine Isotopes Market Size by Region (2015-2020) |
|
| 8.4.1 China | |
| 8.4.2 Japan | |
| 8.4.3 South Korea | |
| 8.4.4 Southeast Asia | |
| 8.4.5 India | |
| 8.4.6 Australia | |
| 8.4.7 Rest of Asia-Pacific | |
9 Japan |
|
9.1 Japan Nuclear Medicine Isotopes Market Size (2015-2026) |
|
9.2 Japan Nuclear Medicine Isotopes Market Size by Type (2015-2020) |
|
9.3 Japan Nuclear Medicine Isotopes Market Size by Application (2015-2020) |
|
9.4 Japan Nuclear Medicine Isotopes Market Size by Country (2015-2020) |
|
| 9.4.1 Mexico | |
| 9.4.2 Brazil | |
10 Southeast Asia |
|
10.1 Southeast Asia Nuclear Medicine Isotopes Market Size (2015-2026) |
|
10.2 Southeast Asia Nuclear Medicine Isotopes Market Size by Type (2015-2020) |
|
10.3 Southeast Asia Nuclear Medicine Isotopes Market Size by Application (2015-2020) |
|
10.4 Southeast Asia Nuclear Medicine Isotopes Market Size by Country (2015-2020) |
|
| 10.4.1 Turkey | |
| 10.4.2 Saudi Arabia | |
| 10.4.3 UAE | |
| 10.4.4 Rest of Middle East & Africa | |
11 Key Players Profiles |
|
11.1 Company 1 |
|
| 11.1.1 Company 1 Company Details | |
| 11.1.2 Company 1 Business Overview | |
| 11.1.3 Company 1 Nuclear Medicine Isotopes Introduction | |
| 11.1.4 Company 1 Revenue in Nuclear Medicine Isotopes Business (2015-2020)) | |
| 11.1.5 Company 1 Recent Development | |
11.2 Company 2 |
|
| 11.2.1 Company 2 Company Details | |
| 11.2.2 Company 2 Business Overview | |
| 11.2.3 Company 2 Nuclear Medicine Isotopes Introduction | |
| 11.2.4 Company 2 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.2.5 Company 2 Recent Development | |
11.3 Company 3 |
|
| 11.3.1 Company 3 Company Details | |
| 11.3.2 Company 3 Business Overview | |
| 11.3.3 Company 3 Nuclear Medicine Isotopes Introduction | |
| 11.3.4 Company 3 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.3.5 Company 3 Recent Development | |
11.4 Company 4 |
|
| 11.4.1 Company 4 Company Details | |
| 11.4.2 Company 4 Business Overview | |
| 11.4.3 Company 4 Nuclear Medicine Isotopes Introduction | |
| 11.4.4 Company 4 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.4.5 Company 4 Recent Development | |
11.5 Company 5 |
|
| 11.5.1 Company 5 Company Details | |
| 11.5.2 Company 5 Business Overview | |
| 11.5.3 Company 5 Nuclear Medicine Isotopes Introduction | |
| 11.5.4 Company 5 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.5.5 Company 5 Recent Development | |
11.6 Company 6 |
|
| 11.6.1 Company 6 Company Details | |
| 11.6.2 Company 6 Business Overview | |
| 11.6.3 Company 6 Nuclear Medicine Isotopes Introduction | |
| 11.6.4 Company 6 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.6.5 Company 6 Recent Development | |
11.7 Company 7 |
|
| 11.7.1 Company 7 Company Details | |
| 11.7.2 Company 7 Business Overview | |
| 11.7.3 Company 7 Nuclear Medicine Isotopes Introduction | |
| 11.7.4 Company 7 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.7.5 Company 7 Recent Development | |
| 二〇二〇年至2026年全球核醫(yī)學(xué)同位素行業(yè)的深入研究和趨勢(shì)分析報(bào)告 | |
11.8 Company 8 |
|
| 11.8.1 Company 8 Company Details | |
| 11.8.2 Company 8 Business Overview | |
| 11.8.3 Company 8 Nuclear Medicine Isotopes Introduction | |
| 11.8.4 Company 8 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.8.5 Company 8 Recent Development | |
11.9 Company 9 |
|
| 11.9.1 Company 9 Company Details | |
| 11.9.2 Company 9 Business Overview | |
| 11.9.3 Company 9 Nuclear Medicine Isotopes Introduction | |
| 11.9.4 Company 9 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.9.5 Company 9 Recent Development | |
11.10 Company 10 |
|
| 11.10.1 Company 10 Company Details | |
| 11.10.2 Company 10 Business Overview | |
| 11.10.3 Company 10 Nuclear Medicine Isotopes Introduction | |
| 11.10.4 Company 10 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 11.10.5 Company 10 Recent Development | |
11.11 Company 11 |
|
| 10.11.1 Company 11 Company Details | |
| 10.11.2 Company 11 Business Overview | |
| 10.11.3 Company 11 Nuclear Medicine Isotopes Introduction | |
| 10.11.4 Company 11 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.11.5 Company 11 Recent Development | |
11.12 Company 12 |
|
| 10.12.1 Company 12 Company Details | |
| 10.12.2 Company 12 Business Overview | |
| 10.12.3 Company 12 Nuclear Medicine Isotopes Introduction | |
| 10.12.4 Company 12 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.12.5 Company 12 Recent Development | |
11.13 Company 13 |
|
| 10.13.1 Company 13 Company Details | |
| 10.13.2 Company 13 Business Overview | |
| 10.13.3 Company 13 Nuclear Medicine Isotopes Introduction | |
| 10.13.4 Company 13 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.13.5 Company 13 Recent Development | |
11.14 Company 14 |
|
| 10.14.1 Company 14 Company Details | |
| 10.14.2 Company 14 Business Overview | |
| 10.14.3 Company 14 Nuclear Medicine Isotopes Introduction | |
| 10.14.4 Company 14 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.14.5 Company 14 Recent Development | |
11.15 Company 15 |
|
| 10.15.1 Company 15 Company Details | |
| 10.15.2 Company 15 Business Overview | |
| 10.15.3 Company 15 Nuclear Medicine Isotopes Introduction | |
| 10.15.4 Company 15 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.15.5 Company 15 Recent Development | |
11.16 Company 16 |
|
| 10.16.1 Company 16 Company Details | |
| 10.16.2 Company 16 Business Overview | |
| 10.16.3 Company 16 Nuclear Medicine Isotopes Introduction | |
| 10.16.4 Company 16 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.16.5 Company 16 Recent Development | |
11.17 Company 17 |
|
| 10.17.1 Company 17 Company Details | |
| 10.17.2 Company 17 Business Overview | |
| 10.17.3 Company 17 Nuclear Medicine Isotopes Introduction | |
| 10.17.4 Company 17 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.17.5 Company 17 Recent Development | |
11.18 Company 18 |
|
| 10.18.1 Company 18 Company Details | |
| 10.18.2 Company 18 Business Overview | |
| 10.18.3 Company 18 Nuclear Medicine Isotopes Introduction | |
| 10.18.4 Company 18 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.18.5 Company 18 Recent Development | |
11.19 Company 19 |
|
| 10.19.1 Company 19 Company Details | |
| 10.19.2 Company 19 Business Overview | |
| 10.19.3 Company 19 Nuclear Medicine Isotopes Introduction | |
| 10.19.4 Company 19 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.19.5 Company 19 Recent Development | |
11.20 Company 20 |
|
| 10.20.1 Company 20 Company Details | |
| 10.20.2 Company 20 Business Overview | |
| 10.20.3 Company 20 Nuclear Medicine Isotopes Introduction | |
| 10.20.4 Company 20 Revenue in Nuclear Medicine Isotopes Business (2015-2020) | |
| 10.20.5 Company 20 Recent Development | |
12 Analyst's Viewpoints/Conclusions |
|
13 Appendix |
|
13.1 Research Methodology |
|
| 13.1.1 Methodology/Research Approach | |
| 13.1.2 Data Source | |
13.2 Disclaimer |
|
13.3 Author Details |
|
| List of Tables | |
| Table 1. Global Nuclear Medicine Isotopes Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 | |
| Table 3. Key Players of Stable Isotopes | |
| Table 4. Key Players of Radioisotopes | |
| 二〇二〇年至2026年全球核醫(yī)學(xué)同位素行業(yè)的深入研究和趨勢(shì)分析報(bào)告 | |
| Table 5. Global Nuclear Medicine Isotopes Market Size Growth by Application (US$ Million): 2020 VS 2026 | |
| Table 6. Global Nuclear Medicine Isotopes Market Size by Regions (US$ Million): 2020 VS 2026 | |
| Table 7. Global Nuclear Medicine Isotopes Market Size by Regions (2015-2020) (US$ Million) | |
| Table 8. Global Nuclear Medicine Isotopes Market Share by Regions (2015-2020) | |
| Table 9. Global Nuclear Medicine Isotopes Forecasted Market Size by Regions (2021-2026) (US$ Million) | |
| Table 10. Global Nuclear Medicine Isotopes Market Share by Regions (2021-2026) | |
| Table 11. Nuclear Medicine Isotopes Market Market Trends | |
| Table 12. Nuclear Medicine Isotopes Market Drivers | |
| Table 13. Nuclear Medicine Isotopes Market Challenges | |
| Table 14. Nuclear Medicine Isotopes Market Restraints | |
| Table 15. Global Nuclear Medicine Isotopes Revenue by Players (2015-2020) (US$ Million) | |
| Table 16. Global Nuclear Medicine Isotopes Market Share by Players (2015-2020) | |
| Table 17. Global Top Nuclear Medicine Isotopes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine Isotopes as of 2019) | |
| Table 18. Global Nuclear Medicine Isotopes by Players Market Concentration Ratio (CR5 and HHI) | |
| Table 19. Key Players Headquarters and Area Served | |
| Table 20. Key Players Nuclear Medicine Isotopes Product Solution and Service | |
| Table 21. Mergers & Acquisitions, Expansion Plans | |
| Table 22. Global Nuclear Medicine Isotopes Market Size by Type (2015-2020) (US$ Million) | |
| Table 23. Global Nuclear Medicine Isotopes Market Size Share by Type (2015-2020) | |
| Table 24. Global Nuclear Medicine Isotopes Revenue Market Share by Type (2021-2026) | |
| Table 25. Global Nuclear Medicine Isotopes Market Size Share by Application (2015-2020) | |
| Table 26. Global Nuclear Medicine Isotopes Market Size by Application (2015-2020) (US$ Million) | |
| Table 27. Global Nuclear Medicine Isotopes Market Size Share by Application (2021-2026) | |
| Table 28. North America Nuclear Medicine Isotopes Market Size by Type (2015-2020) (US$ Million) | |
| Table 29. North America Nuclear Medicine Isotopes Market Share by Type (2015-2020) | |
| Table 30. North America Nuclear Medicine Isotopes Market Size by Application (2015-2020) (US$ Million) | |
| Table 31. North America Nuclear Medicine Isotopes Market Share by Application (2015-2020) | |
| Table 32. North America Nuclear Medicine Isotopes Market Size by Country (US$ Million) (2015-2020) | |
| Table 33. North America Nuclear Medicine Isotopes Market Share by Country (2015-2020) | |
| Table 34. Europe Nuclear Medicine Isotopes Market Size by Type (2015-2020) (US$ Million) | |
| Table 35. Europe Nuclear Medicine Isotopes Market Share by Type (2015-2020) | |
| Table 36. Europe Nuclear Medicine Isotopes Market Size by Application (2015-2020) (US$ Million) | |
| Table 37. Europe Nuclear Medicine Isotopes Market Share by Application (2015-2020) | |
| Table 38. Europe Nuclear Medicine Isotopes Market Size by Country (US$ Million) (2015-2020) | |
| Table 39. Europe Nuclear Medicine Isotopes Market Share by Country (2015-2020) | |
| Table 40. China Nuclear Medicine Isotopes Market Size by Type (2015-2020) (US$ Million) | |
| Table 41. China Nuclear Medicine Isotopes Market Share by Type (2015-2020) | |
| Table 42. China Nuclear Medicine Isotopes Market Size by Application (2015-2020) (US$ Million) | |
| Table 43. China Nuclear Medicine Isotopes Market Share by Application (2015-2020) | |
| Table 44. China Nuclear Medicine Isotopes Market Size by Region (US$ Million) (2015-2020) | |
| Table 45. China Nuclear Medicine Isotopes Market Share by Region (2015-2020) | |
| Table 46. Japan Nuclear Medicine Isotopes Market Size by Type (2015-2020) (US$ Million) | |
| Table 47. Japan Nuclear Medicine Isotopes Market Share by Type (2015-2020) | |
| Table 48. Japan Nuclear Medicine Isotopes Market Size by Application (2015-2020) (US$ Million) | |
| Table 49. Japan Nuclear Medicine Isotopes Market Share by Application (2015-2020) | |
| Table 50. Japan Nuclear Medicine Isotopes Market Size by Country (US$ Million) (2015-2020) | |
| Table 51. Japan Nuclear Medicine Isotopes Market Share by Country (2015-2020) | |
| Table 52. Southeast Asia Nuclear Medicine Isotopes Market Size by Type (2015-2020) (US$ Million) | |
| Table 53. Southeast Asia Nuclear Medicine Isotopes Market Share by Type (2015-2020) | |
| Table 54. Southeast Asia Nuclear Medicine Isotopes Market Size by Application (2015-2020) (US$ Million) | |
| Table 55. Southeast Asia Nuclear Medicine Isotopes Market Share by Application (2015-2020) | |
| Table 56. Southeast Asia Nuclear Medicine Isotopes Market Size by Country (US$ Million) (2015-2020) | |
| Table 57. Southeast Asia Nuclear Medicine Isotopes Market Share by Country (2015-2020) | |
| Table 58. Company 1 Company Details | |
| Table 59. Company 1 Business Overview | |
| Table 60. Company 1 Product | |
| Table 61. Company 1 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 62. Company 1 Recent Development | |
| Table 63. Company 2 Company Details | |
| Table 64. Company 2 Business Overview | |
| Table 65. Company 2 Product | |
| Table 66. Company 2 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 67. Company 2 Recent Development | |
| Table 68. Company 3 Company Details | |
| Table 69. Company 3 Business Overview | |
| Table 70. Company 3 Product | |
| Table 71. Company 3 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 72. Company 3 Recent Development | |
| Table 73. Company 4 Company Details | |
| Table 74. Company 4 Business Overview | |
| Table 75. Company 4 Product | |
| Table 76. Company 4 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 77. Company 4 Recent Development | |
| Table 78. Company 5 Company Details | |
| Table 79. Company 5 Business Overview | |
| Table 80. Company 5 Product | |
| Table 81. Company 5 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 82. Company 5 Recent Development | |
| Table 83. Company 6 Company Details | |
| Table 84. Company 6 Business Overview | |
| Table 85. Company 6 Product | |
| Table 86. Company 6 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 87. Company 6 Recent Development | |
| Table 88. Company 7 Company Details | |
| Table 89. Company 7 Business Overview | |
| Table 90. Company 7 Product | |
| èr líng èr líng nián zhì 2026 nián quánqiú hé yīxué tóngwèisù hángyè de shēnrù yánjiū hé qūshì fēnxī bàogào | |
| Table 91. Company 7 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 92. Company 7 Recent Development | |
| Table 93. Company 8 Business Overview | |
| Table 94. Company 8 Product | |
| Table 95. Company 8 Company Details | |
| Table 96. Company 8 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 97. Company 8 Recent Development | |
| Table 98. Company 9 Company Details | |
| Table 99. Company 9 Business Overview | |
| Table 100. Company 9 Product | |
| Table 101. Company 9 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 102. Company 9 Recent Development | |
| Table 103. Company 10 Company Details | |
| Table 104. Company 10 Business Overview | |
| Table 105. Company 10 Product | |
| Table 106. Company 10 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 107. Company 10 Recent Development | |
| Table 108. Company 11 Company Details | |
| Table 109. Company 11 Business Overview | |
| Table 110. Company 11 Product | |
| Table 111. Company 11 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 112. Company 11 Recent Development | |
| Table 113. Company 12 Company Details | |
| Table 114. Company 12 Business Overview | |
| Table 115. Company 12 Product | |
| Table 116. Company 12 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 117. Company 12 Recent Development | |
| Table 118. Company 13 Company Details | |
| Table 119. Company 13 Business Overview | |
| Table 120. Company 13 Product | |
| Table 121. Company 13 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 122. Company 13 Recent Development | |
| Table 123. Company 14 Company Details | |
| Table 124. Company 14 Business Overview | |
| Table 125. Company 14 Product | |
| Table 126. Company 14 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 127. Company 14 Recent Development | |
| Table 128. Company 15 Company Details | |
| Table 129. Company 15 Business Overview | |
| Table 130. Company 15 Product | |
| Table 131. Company 15 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 132. Company 15 Recent Development | |
| Table 133. Company 16 Company Details | |
| Table 134. Company 16 Business Overview | |
| Table 135. Company 16 Product | |
| Table 136. Company 16 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 137. Company 16 Recent Development | |
| Table 138. Company 17 Company Details | |
| Table 139. Company 17 Business Overview | |
| Table 140. Company 17 Product | |
| Table 141. Company 17 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 142. Company 17 Recent Development | |
| Table 143. Company 18 Company Details | |
| Table 144. Company 18 Business Overview | |
| Table 145. Company 18 Product | |
| Table 146. Company 18 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 147. Company 18 Recent Development | |
| Table 148. Company 19 Company Details | |
| Table 149. Company 19 Business Overview | |
| Table 150. Company 19 Product | |
| Table 151. Company 19 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 152. Company 19 Recent Development | |
| Table 153. Company 20 Company Details | |
| Table 154. Company 20 Business Overview | |
| Table 155. Company 20 Product | |
| Table 156. Company 20 Revenue in Nuclear Medicine Isotopes Business (2015-2020) (US$ Million) | |
| Table 157. Company 20 Recent Development | |
| Table 158. Research Programs/Design for This Report | |
| Table 159. Key Data Information from Secondary Sources | |
| Table 160. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Global Nuclear Medicine Isotopes Market Share by Type: 2020 VS 2026 | |
| Figure 2. Stable Isotopes Features | |
| Figure 3. Radioisotopes Features | |
| Figure 4. Global Nuclear Medicine Isotopes Market Share by Application: 2020 VS 2026 | |
| Figure 5. Nuclear Therapy Case Studies | |
| Figure 6. Equipment Radioactive Source Case Studies | |
| Figure 7. Diagnosis Case Studies | |
| Figure 8. Nuclear Medicine Isotopes Report Years Considered | |
| Figure 9. Global Nuclear Medicine Isotopes Market Size (US$ Million), YoY Growth 2015-2026 | |
| Figure 10. Global Nuclear Medicine Isotopes Market Share by Regions: 2020 VS 2026 | |
| Figure 11. Global Nuclear Medicine Isotopes Market Share by Regions (2021-2026) | |
| Figure 12. Global Nuclear Medicine Isotopes Market Share by Players in 2019 | |
| Figure 13. Global Top Nuclear Medicine Isotopes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine Isotopes as of 2019 | |
| Figure 14. The Top 10 and 5 Players Market Share by Nuclear Medicine Isotopes Revenue in 2019 | |
| Figure 15. North America Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 16. United States Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 17. Canada Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| 2020-2026グローバル?核醫(yī)學(xué)同位體業(yè)界の深い研究と動(dòng)向分析レポート | |
| Figure 18. Europe Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 19. Germany Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 20. France Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 21. U.K. Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 22. Italy Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 23. Russia Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 24. Nordic Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 25. Rest of Europe Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 26. Asia-Pacific Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 27. China Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 28. Japan Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 29. South Korea Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 30. Southeast Asia Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 31. India Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 32. Australia Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 33. Rest of Asia-Pacific Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 34. Latin America Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 35. Mexico Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 36. Brazil Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 37. Middle East & Africa Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 38. Turkey Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 39. Saudi Arabia Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 40. UAE Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 41. Rest of Middle East & Africa Nuclear Medicine Isotopes Market Size YoY Growth (2015-2026) & (US$ Million) | |
| Figure 42. Company 1 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 43. Company 2 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 44. Company 3 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 45. Company 4 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 46. Company 5 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 47. Company 6 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 48. Company 7 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 49. Company 8 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 50. Company 9 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 51. Company 10 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 52. Company 11 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 53. Company 12 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 54. Company 13 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 55. Company 14 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 56. Company 15 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 57. Company 16 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 58. Company 17 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 59. Company 18 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 60. Company 19 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 61. Company 20 Revenue Growth Rate in Nuclear Medicine Isotopes Business (2015-2020) | |
| Figure 62. Bottom-up and Top-down Approaches for This Report | |
| Figure 63. Data Triangulation | |
| Figure 64. Key Executives Interviewed | |
略……
如需購(gòu)買《2020-2026 Global Nuclear Medicine Isotopes Industry In-Depth Research and Trends Analysis Report》，編號(hào)：2860011
請(qǐng)您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購(gòu)】 ┊ 下載《訂購(gòu)協(xié)議》 ┊ 了解“訂購(gòu)流程”
請(qǐng)您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購(gòu)】 ┊ 下載《訂購(gòu)協(xié)議》 ┊ 了解“訂購(gòu)流程”
京公網(wǎng)安備 11010802027365號(hào)